Jeffry Keyes Sells 37,381 Shares of Quantum-Si (NASDAQ:QSI) Stock
by Tristan Rich · The Markets DailyQuantum-Si Incorporated (NASDAQ:QSI – Get Free Report) CFO Jeffry Keyes sold 37,381 shares of the firm’s stock in a transaction on Tuesday, April 21st. The shares were sold at an average price of $0.99, for a total value of $37,007.19. Following the transaction, the chief financial officer owned 1,732,582 shares in the company, valued at approximately $1,715,256.18. This represents a 2.11% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website.
Quantum-Si Trading Down 11.3%
Shares of Quantum-Si stock opened at $0.94 on Friday. The firm has a market cap of $203.52 million, a P/E ratio of -1.81 and a beta of 3.08. Quantum-Si Incorporated has a 12 month low of $0.69 and a 12 month high of $3.10. The stock’s fifty day moving average price is $0.90 and its 200-day moving average price is $1.27.
Quantum-Si (NASDAQ:QSI – Get Free Report) last announced its quarterly earnings results on Tuesday, March 3rd. The company reported ($0.08) EPS for the quarter, beating the consensus estimate of ($0.14) by $0.06. The firm had revenue of $0.45 million for the quarter, compared to analyst estimates of $0.76 million. Quantum-Si had a negative return on equity of 43.90% and a negative net margin of 4,160.06%. Analysts forecast that Quantum-Si Incorporated will post -0.5 earnings per share for the current year.
Analyst Ratings Changes
Several equities analysts have recently commented on QSI shares. Weiss Ratings restated a “sell (d-)” rating on shares of Quantum-Si in a research note on Friday, March 27th. Canaccord Genuity Group cut their target price on Quantum-Si from $1.50 to $1.00 and set a “hold” rating on the stock in a research note on Wednesday, March 4th. Two equities research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, Quantum-Si currently has an average rating of “Hold” and a consensus target price of $3.25.
Check Out Our Latest Report on Quantum-Si
Hedge Funds Weigh In On Quantum-Si
Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Prudential Financial Inc. purchased a new position in Quantum-Si in the second quarter valued at about $25,000. Cerity Partners LLC purchased a new position in Quantum-Si in the second quarter valued at about $29,000. Capital Investment Advisory Services LLC grew its stake in Quantum-Si by 100.0% in the third quarter. Capital Investment Advisory Services LLC now owns 20,000 shares of the company’s stock valued at $28,000 after purchasing an additional 10,000 shares during the last quarter. Elite Life Management LLC purchased a new position in Quantum-Si in the third quarter valued at about $29,000. Finally, HBK Sorce Advisory LLC purchased a new position in Quantum-Si in the third quarter valued at about $30,000. Hedge funds and other institutional investors own 39.90% of the company’s stock.
About Quantum-Si
Quantum-Si Inc is a life sciences instrumentation company headquartered in Guilford, Connecticut, developing next-generation proteomics solutions based on semiconductor sequencing technology. The company’s core offering centers on a proprietary single-molecule protein sequencing platform that uses a silicon-based sensor chip to convert protein data into digital signals. This approach is designed to deliver high sensitivity, single-amino-acid resolution and deep proteome coverage while potentially reducing cost and complexity compared to traditional mass spectrometry methods.
Quantum-Si’s product roadmap includes the development and commercialization of an integrated system comprising instruments, consumable reagents and proprietary data analysis software.